-+ 0.00%
-+ 0.00%
-+ 0.00%

BridgeBio Oncology Therapeutics’ Principal Accounting Officer Marc Cobo files Form 3 ownership statement

PUBT·04/30/2026 20:35:41
Listen to the news
BridgeBio Oncology Therapeutics’ Principal Accounting Officer Marc Cobo files Form 3 ownership statement
  • BridgeBio Oncology Therapeutics principal accounting officer Marc Cobo filed an initial Form 3 disclosing 5,431 common shares.
  • Filing also reported stock options covering 154,215 shares with exercise prices of $9.59-$10.19.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bridgebio Oncology Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-197373), on April 30, 2026, and is solely responsible for the information contained therein.